npj Precision Oncology is an open access, peer-reviewed journal dedicated to advancing the field of precision oncology. Published in partnership with Nature Portfolio, the journal focuses on innovative research that leverages genomic, proteomic, and other molecular data to personalize cancer treatment. Covers personalized cancer treatment using genomic, proteomic, and molecular data, while focusing on precise treatment applications.
The journal covers a wide range of topics including cancer genomics, molecular diagnostics, targeted therapies, immunotherapy, and clinical trials. Indexed in major databases, npj Precision Oncology is a key resource for oncologists, researchers, and other healthcare professionals working to improve cancer care.
npj Precision Oncology aims to accelerate the development and implementation of precision oncology approaches to improve patient outcomes and transform cancer treatment. It encourages submissions that showcase innovative research with the potential for significant clinical impact. Consider submitting your research to help shape the future of precision oncology.